UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnostic utility of the lymphoid screening tube supplemented with TRBC1 for the assessment of T‐cell clonality

International journal of laboratory hematology, 2023-08, Vol.45 (4), p.496-505

2023

Volltextzugriff (PDF)

HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE

Hematological oncology, 2023-06, Vol.41 (S2), p.207-208

2023

Volltextzugriff (PDF)

Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)

Hematological oncology, 2023-06, Vol.41 (S2), p.437-437

2023

Volltextzugriff (PDF)

PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA‐R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS‐5)

HemaSphere, 2022-06, Vol.6 (Suppl), p.1989-1990

2022

Volltextzugriff (PDF)

P1214: SUBCUTANEOUS EPCORITAMAB + R‐CHOP FOR FIRST‐LINE TREATMENT OF PATIENTS WITH HIGH‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA: PHASE 1/2 UPDATE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1100-1101

2022

Volltextzugriff (PDF)

In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection

Leukemia, 2014-04, Vol.28 (4), p.830-841

2014

Volltextzugriff (PDF)

HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.49-50

2019

Volltextzugriff (PDF)

79 Intravenous colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis (CF) patients

Journal of cystic fibrosis, 2014-06, Vol.13, p.S66-S66

2014

Volltextzugriff (PDF)

Exploring Betty A. Reardon's Perspective on Peace Education: Looking Back, Looking Forward

1st ed. 2019., 2019

Volltextzugriff (PDF)

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

The Lancet. Haematology, 2019-08, Vol.6 (8), p.e429-e437

2019

Volltextzugriff (PDF)

Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

British journal of haematology, 2020-04, Vol.189 (1), p.84-96

2020

Volltextzugriff (PDF)

Betty A. Reardon: Key Texts in Gender and Peace

2015., 2014

Volltextzugriff (PDF)

EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.437

2023

Volltextzugriff (PDF)

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

Haematologica (Roma), 2012-10, Vol.97 (10), p.1539-1547

2012

Volltextzugriff (PDF)

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Genome medicine, 2023-04, Vol.15 (1), p.22-22, Article 22

2023

Volltextzugriff (PDF)

Protocol for venoarterial ExtraCorporeal Membrane Oxygenation to reduce morbidity and mortality following bilateral lung TransPlantation: the ECMOToP randomised controlled trial

BMJ open, 2024-03, Vol.14 (3), p.e077770-e077770

2024

Volltextzugriff (PDF)

Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: a randomized, controlled clinical trial

Trials, 2024-02, Vol.25 (1), p.126-126, Article 126

2024

Volltextzugriff (PDF)

PF384 EFFECTIVENESS AND SAFETY OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ROUTINE CLINICAL PRACTICE: INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL‐WORLD DATA (BIRD) STUDY

HemaSphere, 2019-06, Vol.3 (S1), p.144-n/a

2019

Volltextzugriff (PDF)

PF494 CLINICAL OUTCOMES WITH SINGLE‐AGENT IBRUTINIB FOR RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL‐WORLD DATA (BIRD) STUDY

HemaSphere, 2019-06, Vol.3 (S1), p.199-200

2019

Volltextzugriff (PDF)

Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction

Respiratory research, 2024-02, Vol.25 (1), p.88-88, Article 88

2024

Volltextzugriff (PDF)

Subcutaneous Epcoritamab in Combination with Rituximab plus Lenalidomide (R 2 ) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial

BLOOD, 2022, Vol.140, p.1471

2022

Volltextzugriff (PDF)

In vitro generation of mature, naive antigen-specific [CD8.sup.+] T cells with a single T-cell receptor by agonist selection

Leukemia, 2014-05, Vol.28 (4), p.830

2014

Volltextzugriff (PDF)

In vitro generation of mature, naive antigen-specific CD8 super(+) T cells with a single T-cell receptor by agonist selection

Leukemia, 2014-04, Vol.28 (4), p.830-841

2014

Volltextzugriff (PDF)

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Genome medicine, 2024-01, Vol.16 (1), p.6-6, Article 6

2024

Volltextzugriff (PDF)

1 – 25 von 544

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(387)
Mit Volltextzugriff
(456)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(212)
Life Sciences & Biomedicine
(166)
Humans
(91)
Education
(53)
Biological And Medical Sciences
(47)
Microbiology
(47)
Human Rights
(46)
International Relations
(45)
Male
(36)
Female
(35)
Social Sciences
(35)
Physical Sciences
(34)
Technology
(34)
Rna, Ribosomal, 16s - Genetics
(31)
Fundamental And Applied Biological Sciences. Psychology
(30)
Molecular Sequence Data
(30)
Education & Educational Research
(28)
Phylogeny
(28)
Medicine
(26)
Animals
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Diagnostic utility of the lymphoid screening tube supplemented with TRBC1 for the assessment of T‐cell clonality

HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE

Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)

PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA‐R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS‐5)

P1214: SUBCUTANEOUS EPCORITAMAB + R‐CHOP FOR FIRST‐LINE TREATMENT OF PATIENTS WITH HIGH‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA: PHASE 1/2 UPDATE

In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection

HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY

79 Intravenous colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis (CF) patients

Exploring Betty A. Reardon's Perspective on Peace Education: Looking Back, Looking Forward

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

Betty A. Reardon: Key Texts in Gender and Peace

EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Protocol for venoarterial ExtraCorporeal Membrane Oxygenation to reduce morbidity and mortality following bilateral lung TransPlantation: the ECMOToP randomised controlled trial

Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: a randomized, controlled clinical trial

PF384 EFFECTIVENESS AND SAFETY OF IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ROUTINE CLINICAL PRACTICE: INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL‐WORLD DATA (BIRD) STUDY

PF494 CLINICAL OUTCOMES WITH SINGLE‐AGENT IBRUTINIB FOR RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): INTERIM ANALYSIS (IA) OF THE BELGIAN IBRUTINIB REAL‐WORLD DATA (BIRD) STUDY

Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction

Subcutaneous Epcoritamab in Combination with Rituximab plus Lenalidomide (R 2 ) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial

In vitro generation of mature, naive antigen-specific [CD8.sup.+] T cells with a single T-cell receptor by agonist selection

In vitro generation of mature, naive antigen-specific CD8 super(+) T cells with a single T-cell receptor by agonist selection

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Suchergebnisse filtern